Search for Clinical Trial Results

Sponsored By

Hereditary Angioedema - 13 Studies Found

Status Study
COMPLETED Study Name: Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II
Condition: Hereditary Angioedema
Date: 2026-01-12
Interventions: Deucrictibant softgel capsules for oral use (PHVS416)
COMPLETED Study Name: A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr�) in Persons With HAE in China
Condition: Hereditary Angioedema (HAE)
Date: 2026-01-12
Interventions: This is a non-interventional study.
COMPLETED Study Name: A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Date: 2026-01-12
Interventions: Icatibant, 10 to 30 mg, Subcutaneous injection
<<< Previous